Fall Semester 2026–2027 PED320 – Pediatric Pharmacology
Updated 2026 | 190+ Questions and Answers | PED320
Pediatric Pharmacology Comprehensive Study Guide, Practice
Exam, Exam Prep Test Bank, Pediatric Medication
Administration, Weight-Based Dosage Calculations, Pediatric
Drug Classifications, Neonatal Pharmacology, Immunizations,
Pediatric Emergency Medications, Medication Safety, Adverse
Drug Reactions, Clinical Judgment, Next Generation NCLEX
(NGN), Detailed Rationales and Complete Revision Material
Question 1: A 4-year-old patient is prescribed a medication that is primarily
metabolized by the CYP3A4 enzyme system. The prescriber notes that the
patient has a genetic polymorphism resulting in poor metabolizer status for
this isoenzyme. What is the most appropriate initial action regarding the
dosage of this medication?
A. Increase the dose by 50% to achieve therapeutic levels.
B. Administer a loading dose to rapidly achieve steady-state concentrations.
C. Initiate therapy at a lower dose and titrate carefully based on clinical response and
serum levels.
D. Maintain the standard weight-based dose as pediatric clearance is independent of
metabolic pathways.
CORRECT ANSWER: C. Initiate therapy at a lower dose and titrate carefully
based on clinical response and serum levels.
Rationale: A poor metabolizer phenotype for CYP3A4 results in reduced drug clearance,
leading to higher and potentially toxic plasma concentrations. The safest approach is to
start with a lower dose and adjust based on therapeutic drug monitoring and clinical
response. Increasing the dose or maintaining standard dosing would increase toxicity
risk, and genetic status significantly impacts pediatric drug metabolism.
Question 2: A 6-month-old infant is diagnosed with a severe bacterial infection
and requires an aminoglycoside. Which pharmacokinetic parameter is most
significantly altered in this age group compared to older children and adults,
necessitating careful dosing adjustments?
A. Decreased total body water percentage.
B. Increased glomerular filtration rate relative to body surface area.
C. Decreased hepatic blood flow.
D. Increased protein binding due to elevated alpha-1-acid glycoprotein.
CORRECT ANSWER: B. Increased glomerular filtration rate relative to body
surface area.
Rationale: Infants have a higher glomerular filtration rate per body surface area than
older children and adults, leading to more rapid renal clearance of drugs like
aminoglycosides. This often requires higher weight-based doses or shorter dosing
,intervals. Total body water is higher in infants, hepatic blood flow changes are variable,
and protein binding is typically decreased due to lower plasma protein concentrations.
Question 3: A 10-year-old child with asthma is prescribed beclomethasone
dipropionate via inhalation. To minimize systemic adverse effects while
ensuring adequate local pulmonary activity, the prescriber emphasizes proper
inhaler technique. What is the primary physiological rationale for this
instruction?
A. To ensure the drug is absorbed in the oropharynx for systemic effect.
B. To maximize deposition in the large conducting airways where glucocorticoid
receptors are most dense.
C. To reduce the swallowed fraction of the drug, thereby limiting first-pass hepatic
metabolism to active metabolites.
D. To minimize oropharyngeal deposition and subsequent gastrointestinal absorption,
reducing hypothalamic-pituitary-adrenal (HPA) axis suppression.
CORRECT ANSWER: D. To minimize oropharyngeal deposition and subsequent
gastrointestinal absorption, reducing hypothalamic-pituitary-adrenal (HPA)
axis suppression.
Rationale: Improper technique leads to oropharyngeal deposition. The swallowed
portion is absorbed from the GI tract and undergoes first-pass metabolism, but a
significant fraction reaches the systemic circulation, potentially causing HPA axis
suppression. Proper technique maximizes pulmonary delivery where local action is
desired and minimizes systemic exposure from the GI route.
Question 4: A neonate in the NICU is receiving intravenous fentanyl for
analgesia. The pharmacist notes that the infant has developed a rigid chest
wall and significant respiratory depression shortly after a bolus dose. What is
the most appropriate pharmacological intervention?
A. Administer naloxone.
B. Administer flumazenil.
C. Administer a neuromuscular blocker and provide mechanical ventilation.
D. Administer a dose of intravenous lipid emulsion.
CORRECT ANSWER: A. Administer naloxone.
Rationale: Fentanyl-induced chest wall rigidity and respiratory depression are opioid-
mediated effects. Naloxone, a competitive opioid antagonist, is the specific antidote.
Flumazenil is for benzodiazepine overdose, neuromuscular blockade does not reverse
the opioid effect, and lipid emulsion is used for local anesthetic toxicity.
,Question 5: A pediatric patient with epilepsy is being transitioned from
phenytoin to levetiracetam due to concerns about long-term cognitive effects.
The prescriber initiates levetiracetam and begins to taper phenytoin. What is
the most critical pharmacokinetic consideration during this transition?
A. Levetiracetam significantly increases phenytoin clearance requiring a rapid phenytoin
taper.
B. Phenytoin induces the metabolism of levetiracetam, requiring higher levetiracetam
doses.
C. Both drugs are highly protein-bound and compete for binding sites, increasing free
phenytoin levels.
D. Phenytoin is a potent enzyme inducer, and its withdrawal may increase levetiracetam
concentrations.
CORRECT ANSWER: D. Phenytoin is a potent enzyme inducer, and its
withdrawal may increase levetiracetam concentrations.
Rationale: Phenytoin induces hepatic CYP450 enzymes. As it is tapered and withdrawn,
enzyme activity decreases, potentially leading to increased serum concentrations of co-
administered drugs metabolized by these pathways, including levetiracetam. Close
monitoring for levetiracetam toxicity (e.g., sedation, behavioral changes) is warranted.
Phenytoin is highly protein-bound but levetiracetam is not, making displacement
interactions unlikely.
Question 6: A 2-year-old child presents with a febrile seizure. The parents are
concerned about the child's temperature of 39.5°C and request an antipyretic.
The physician recommends acetaminophen 15 mg/kg. What is the primary
mechanism of action for this drug at the therapeutic dose used in this
scenario?
A. Inhibition of cyclooxygenase-1 (COX-1) in the peripheral tissues.
B. Inhibition of cyclooxygenase-2 (COX-2) in the central nervous system.
C. Inhibition of prostaglandin synthesis in the hypothalamus via the peroxidase
component of COX.
D. Activation of cannabinoid receptors in the brainstem.
CORRECT ANSWER: C. Inhibition of prostaglandin synthesis in the
hypothalamus via the peroxidase component of COX.
Rationale: Acetaminophen's antipyretic effect is primarily central. It inhibits the COX
enzyme, particularly its peroxidase component, in the hypothalamus, reducing
prostaglandin E2 synthesis, which resets the hypothalamic set point. Its peripheral anti-
inflammatory effect is weak, and it does not significantly inhibit COX-1 or COX-2 in
peripheral tissues at therapeutic doses.
, Question 7: An 8-year-old child with acute lymphoblastic leukemia is receiving
high-dose methotrexate. To prevent nephrotoxicity and enhance drug
elimination, the treatment protocol includes aggressive hydration and
alkalinization of the urine. What is the specific rationale for urine
alkalinization?
A. To increase the renal tubular reabsorption of methotrexate.
B. To increase the ionization of methotrexate, preventing its precipitation in the renal
tubules.
C. To reduce the metabolism of methotrexate to its active polyglutamate form.
D. To enhance the binding of methotrexate to plasma proteins.
CORRECT ANSWER: B. To increase the ionization of methotrexate, preventing
its precipitation in the renal tubules.
Rationale: Methotrexate and its metabolites are weak acids. In alkaline urine, they are
more ionized and less likely to be reabsorbed, promoting excretion. More importantly,
alkalinization increases their solubility, reducing the risk of precipitation and subsequent
acute kidney injury. It does not affect metabolism or protein binding.
Question 8: A 5-year-old patient is prescribed oral liquid amoxicillin for acute
otitis media. The medication guide instructs parents to shake the bottle well
before each use. What is the primary pharmaceutical reason for this
instruction?
A. To ensure the drug is evenly distributed throughout the suspension.
B. To aerate the liquid to improve palatability.
C. To activate the drug's chemical structure for optimal absorption.
D. To dissolve any crystallized drug that has formed on the bottom.
CORRECT ANSWER: A. To ensure the drug is evenly distributed throughout the
suspension.
Rationale: Amoxicillin suspension is a heterogeneous mixture (suspension) where drug
particles settle over time. Shaking ensures a uniform distribution so that the correct
dose is administered each time. It is not an aerating agent, its activation is pH-
dependent, and crystals do not typically form in this manner.
Question 9: A 14-year-old male with severe acne is started on isotretinoin.
What is the most critical laboratory monitoring parameter to assess prior to
initiating therapy and at regular intervals throughout the treatment course?
A. Complete blood count with differential.
B. Serum triglycerides and liver function tests.
C. Serum creatinine and BUN.
D. Serum cortisol and ACTH levels.
Updated 2026 | 190+ Questions and Answers | PED320
Pediatric Pharmacology Comprehensive Study Guide, Practice
Exam, Exam Prep Test Bank, Pediatric Medication
Administration, Weight-Based Dosage Calculations, Pediatric
Drug Classifications, Neonatal Pharmacology, Immunizations,
Pediatric Emergency Medications, Medication Safety, Adverse
Drug Reactions, Clinical Judgment, Next Generation NCLEX
(NGN), Detailed Rationales and Complete Revision Material
Question 1: A 4-year-old patient is prescribed a medication that is primarily
metabolized by the CYP3A4 enzyme system. The prescriber notes that the
patient has a genetic polymorphism resulting in poor metabolizer status for
this isoenzyme. What is the most appropriate initial action regarding the
dosage of this medication?
A. Increase the dose by 50% to achieve therapeutic levels.
B. Administer a loading dose to rapidly achieve steady-state concentrations.
C. Initiate therapy at a lower dose and titrate carefully based on clinical response and
serum levels.
D. Maintain the standard weight-based dose as pediatric clearance is independent of
metabolic pathways.
CORRECT ANSWER: C. Initiate therapy at a lower dose and titrate carefully
based on clinical response and serum levels.
Rationale: A poor metabolizer phenotype for CYP3A4 results in reduced drug clearance,
leading to higher and potentially toxic plasma concentrations. The safest approach is to
start with a lower dose and adjust based on therapeutic drug monitoring and clinical
response. Increasing the dose or maintaining standard dosing would increase toxicity
risk, and genetic status significantly impacts pediatric drug metabolism.
Question 2: A 6-month-old infant is diagnosed with a severe bacterial infection
and requires an aminoglycoside. Which pharmacokinetic parameter is most
significantly altered in this age group compared to older children and adults,
necessitating careful dosing adjustments?
A. Decreased total body water percentage.
B. Increased glomerular filtration rate relative to body surface area.
C. Decreased hepatic blood flow.
D. Increased protein binding due to elevated alpha-1-acid glycoprotein.
CORRECT ANSWER: B. Increased glomerular filtration rate relative to body
surface area.
Rationale: Infants have a higher glomerular filtration rate per body surface area than
older children and adults, leading to more rapid renal clearance of drugs like
aminoglycosides. This often requires higher weight-based doses or shorter dosing
,intervals. Total body water is higher in infants, hepatic blood flow changes are variable,
and protein binding is typically decreased due to lower plasma protein concentrations.
Question 3: A 10-year-old child with asthma is prescribed beclomethasone
dipropionate via inhalation. To minimize systemic adverse effects while
ensuring adequate local pulmonary activity, the prescriber emphasizes proper
inhaler technique. What is the primary physiological rationale for this
instruction?
A. To ensure the drug is absorbed in the oropharynx for systemic effect.
B. To maximize deposition in the large conducting airways where glucocorticoid
receptors are most dense.
C. To reduce the swallowed fraction of the drug, thereby limiting first-pass hepatic
metabolism to active metabolites.
D. To minimize oropharyngeal deposition and subsequent gastrointestinal absorption,
reducing hypothalamic-pituitary-adrenal (HPA) axis suppression.
CORRECT ANSWER: D. To minimize oropharyngeal deposition and subsequent
gastrointestinal absorption, reducing hypothalamic-pituitary-adrenal (HPA)
axis suppression.
Rationale: Improper technique leads to oropharyngeal deposition. The swallowed
portion is absorbed from the GI tract and undergoes first-pass metabolism, but a
significant fraction reaches the systemic circulation, potentially causing HPA axis
suppression. Proper technique maximizes pulmonary delivery where local action is
desired and minimizes systemic exposure from the GI route.
Question 4: A neonate in the NICU is receiving intravenous fentanyl for
analgesia. The pharmacist notes that the infant has developed a rigid chest
wall and significant respiratory depression shortly after a bolus dose. What is
the most appropriate pharmacological intervention?
A. Administer naloxone.
B. Administer flumazenil.
C. Administer a neuromuscular blocker and provide mechanical ventilation.
D. Administer a dose of intravenous lipid emulsion.
CORRECT ANSWER: A. Administer naloxone.
Rationale: Fentanyl-induced chest wall rigidity and respiratory depression are opioid-
mediated effects. Naloxone, a competitive opioid antagonist, is the specific antidote.
Flumazenil is for benzodiazepine overdose, neuromuscular blockade does not reverse
the opioid effect, and lipid emulsion is used for local anesthetic toxicity.
,Question 5: A pediatric patient with epilepsy is being transitioned from
phenytoin to levetiracetam due to concerns about long-term cognitive effects.
The prescriber initiates levetiracetam and begins to taper phenytoin. What is
the most critical pharmacokinetic consideration during this transition?
A. Levetiracetam significantly increases phenytoin clearance requiring a rapid phenytoin
taper.
B. Phenytoin induces the metabolism of levetiracetam, requiring higher levetiracetam
doses.
C. Both drugs are highly protein-bound and compete for binding sites, increasing free
phenytoin levels.
D. Phenytoin is a potent enzyme inducer, and its withdrawal may increase levetiracetam
concentrations.
CORRECT ANSWER: D. Phenytoin is a potent enzyme inducer, and its
withdrawal may increase levetiracetam concentrations.
Rationale: Phenytoin induces hepatic CYP450 enzymes. As it is tapered and withdrawn,
enzyme activity decreases, potentially leading to increased serum concentrations of co-
administered drugs metabolized by these pathways, including levetiracetam. Close
monitoring for levetiracetam toxicity (e.g., sedation, behavioral changes) is warranted.
Phenytoin is highly protein-bound but levetiracetam is not, making displacement
interactions unlikely.
Question 6: A 2-year-old child presents with a febrile seizure. The parents are
concerned about the child's temperature of 39.5°C and request an antipyretic.
The physician recommends acetaminophen 15 mg/kg. What is the primary
mechanism of action for this drug at the therapeutic dose used in this
scenario?
A. Inhibition of cyclooxygenase-1 (COX-1) in the peripheral tissues.
B. Inhibition of cyclooxygenase-2 (COX-2) in the central nervous system.
C. Inhibition of prostaglandin synthesis in the hypothalamus via the peroxidase
component of COX.
D. Activation of cannabinoid receptors in the brainstem.
CORRECT ANSWER: C. Inhibition of prostaglandin synthesis in the
hypothalamus via the peroxidase component of COX.
Rationale: Acetaminophen's antipyretic effect is primarily central. It inhibits the COX
enzyme, particularly its peroxidase component, in the hypothalamus, reducing
prostaglandin E2 synthesis, which resets the hypothalamic set point. Its peripheral anti-
inflammatory effect is weak, and it does not significantly inhibit COX-1 or COX-2 in
peripheral tissues at therapeutic doses.
, Question 7: An 8-year-old child with acute lymphoblastic leukemia is receiving
high-dose methotrexate. To prevent nephrotoxicity and enhance drug
elimination, the treatment protocol includes aggressive hydration and
alkalinization of the urine. What is the specific rationale for urine
alkalinization?
A. To increase the renal tubular reabsorption of methotrexate.
B. To increase the ionization of methotrexate, preventing its precipitation in the renal
tubules.
C. To reduce the metabolism of methotrexate to its active polyglutamate form.
D. To enhance the binding of methotrexate to plasma proteins.
CORRECT ANSWER: B. To increase the ionization of methotrexate, preventing
its precipitation in the renal tubules.
Rationale: Methotrexate and its metabolites are weak acids. In alkaline urine, they are
more ionized and less likely to be reabsorbed, promoting excretion. More importantly,
alkalinization increases their solubility, reducing the risk of precipitation and subsequent
acute kidney injury. It does not affect metabolism or protein binding.
Question 8: A 5-year-old patient is prescribed oral liquid amoxicillin for acute
otitis media. The medication guide instructs parents to shake the bottle well
before each use. What is the primary pharmaceutical reason for this
instruction?
A. To ensure the drug is evenly distributed throughout the suspension.
B. To aerate the liquid to improve palatability.
C. To activate the drug's chemical structure for optimal absorption.
D. To dissolve any crystallized drug that has formed on the bottom.
CORRECT ANSWER: A. To ensure the drug is evenly distributed throughout the
suspension.
Rationale: Amoxicillin suspension is a heterogeneous mixture (suspension) where drug
particles settle over time. Shaking ensures a uniform distribution so that the correct
dose is administered each time. It is not an aerating agent, its activation is pH-
dependent, and crystals do not typically form in this manner.
Question 9: A 14-year-old male with severe acne is started on isotretinoin.
What is the most critical laboratory monitoring parameter to assess prior to
initiating therapy and at regular intervals throughout the treatment course?
A. Complete blood count with differential.
B. Serum triglycerides and liver function tests.
C. Serum creatinine and BUN.
D. Serum cortisol and ACTH levels.
